1,350 research outputs found

    Use of Screen-printed Electrodes Modified by Prussian Blue and Analogues in Sensing of Cysteine

    Get PDF
    © 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim The utilisation of screen-printing technology allows for a mass scalable approach for the production of electrochemical screen-printed electrodes (SPEs) and the presence of a redox mediator can add new possibilities to the electrochemical properties of the SPEs. Among the materials used as redox mediators, cyanidoferrates polymers can be used for electro-oxidation of cysteine. In this work, two monomers, namely, [Fe(CN) 6 ] 4− and [Fe(CN) 5 NH 3 ] 3− were used to produce Prussian blue (PB) and Prussian blue-Ammine (PB-Ammine), respectively. In addition, two modification methods were compared, firstly via a drop-casting and secondly by the incorporation of these materials into a printable ink. The SPE modified by PB-Ammine (drop-casting) exhibits the highest electroactive area, however the highest heterogeneous rate constant was found with the SPE modified by PB-Ammine that was incorporated into the ink. The highest value of the constant of electro-oxidation of cysteine and lowest limit of detection was also observed in the SPE modified by PB incorporated into the ink. These studies suggest that the electrocatalytic properties of SPE modified by PB and PB-Ammine are dependent upon the availability of Fe 3+ catalytic sites and the increased kinetics of the chemical reaction between the catalytic sites and the analyte

    Ni−Fe (Oxy)hydroxide Modified Graphene Additive Manufactured (3D-Printed) Electrochemical Platforms as an Efficient Electrocatalyst for the Oxygen Evolution Reaction

    Get PDF
    © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim We demonstrate that polylactic acid (PLA)/graphene additive manufactured (3D-printed) electrodes (Gr/AMEs) electrodeposited with Ni−Fe (oxy)hydroxide can efficiently catalyse the oxygen evolution reaction (OER). X-ray photoelectron spectroscopy (XPS) depth profiling combined with Atomic Force Microscopy (AFM) and Tip Enhanced Raman Spectroscopy (TERS) deduced the composition and depth of the Ni−Fe (oxy)hydroxide layer. The composition of the resulting electrocatalytic surfaces are tailored through altering the concentrations of nickel and iron within the electrodeposited solutions, which give rise to optimised AMEs OER performance (within 0.1 M KOH). The optimal OER performance was observed from a Ni−Fe (oxy)hydroxide with a 10 % content of Fe, which displayed an OER onset potential and overpotential of+1.47 V (vs. RHE) and 519 mV, respectively. These values arecomparable to that of polycrystalline Iridium (+ 1.43 V (vs. RHE) and ca. 413 mV), as well as being significantly less electropositive than a bare/unmodified AME. This work is essential for those designing, fabricating and modulating additive manufactured electrodes

    Bacteria-Killing Type IV Secretion Systems

    Get PDF
    Bacteria have been constantly competing for nutrients and space for billions of years. During this time, they have evolved many different molecular mechanisms by which to secrete proteinaceous effectors in order to manipulate and often kill rival bacterial and eukaryotic cells. These processes often employ large multimeric transmembrane nanomachines that have been classified as types I–IX secretion systems. One of the most evolutionarily versatile are the Type IV secretion systems (T4SSs), which have been shown to be able to secrete macromolecules directly into both eukaryotic and prokaryotic cells. Until recently, examples of T4SS-mediated macromolecule transfer from one bacterium to another was restricted to protein-DNA complexes during bacterial conjugation. This view changed when it was shown by our group that many Xanthomonas species carry a T4SS that is specialized to transfer toxic bacterial effectors into rival bacterial cells, resulting in cell death. This review will focus on this special subtype of T4SS by describing its distinguishing features, similar systems in other proteobacterial genomes, and the nature of the effectors secreted by these systems and their cognate inhibitor

    Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Duffy blood group polymorphisms are important in areas where <it>Plasmodium vivax </it>predominates, because this molecule acts as a receptor for this protozoan. In the present study, Duffy blood group genotyping in <it>P. vivax </it>malaria patients from four different Brazilian endemic areas is reported, exploring significant associations between blood group variants and susceptibility or resistance to malaria.</p> <p>Methods</p> <p>The <it>P. vivax </it>identification was determined by non-genotypic and genotypic screening tests. The Duffy blood group was genotyped by PCR/RFLP in 330 blood donors and 312 malaria patients from four Brazilian Amazon areas. In order to assess the variables significance and to obtain independence among the proportions, the Fisher's exact test was used.</p> <p>Results</p> <p>The data show a high frequency of the <it>FYA/FYB </it>genotype, followed by <it>FYB/FYB, FYA/FYA</it>, <it>FYA/FYB-33 </it>and <it>FYB/FYB-33</it>. Low frequencies were detected for the <it>FYA/FY</it><sup><it>X</it></sup>, <it>FYB/FY</it><sup><it>X</it></sup>, <it>FYX/FY</it><sup><it>X </it></sup>and <it>FYB-33/FYB-33 </it>genotypes. Negative Duffy genotype (<it>FYB-33/FYB-33</it>) was found in both groups: individuals infected and non-infected (blood donors). No individual carried the <it>FY</it><sup><it>X</it></sup><it>/FYB-33 </it>genotype. Some of the Duffy genotypes frequencies showed significant differences between donors and malaria patients.</p> <p>Conclusion</p> <p>The obtained data suggest that individuals with the <it>FYA/FYB </it>genotype have higher susceptibility to malaria. The presence of the <it>FYB-33 </it>allele may be a selective advantage in the population, reducing the rate of infection by <it>P. vivax </it>in this region. Additional efforts may contribute to better elucidate the physiopathologic differences in this parasite/host relationship in regions endemic for <it>P. vivax </it>malaria, in particular the Brazilian Amazon region.</p

    Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis

    Get PDF
    To assess a role of microsatellite instability (MSI) in the development of gastric adenocarcinoma or adenoma from chronic gastritis, we analysed mutations of five microsatellite loci in gastritis, adenoma and adenocarcinoma retrospectively. Gastric mucosa was biopsied from the same area in each patient at different periods and examined for MSI. Only one of 55 patients with chronic gastritis revealed MSI-H phenotype and the other 54 patients showed microsatellite stable (MSS) phenotypes. In six of 17 patients with gastric adenoma or well-differentiated adenocarcinoma, MSI-positive phenotypes were demonstrated. Interestingly, all of six patients showing MSI, including three high-level MSI (MSI-H) cases and three low-level (MSH-L) cases, had already revealed MSI at the stage of chronic gastritis. In two of three MSI-H cases, the identical MSI patterns had been observed at the stage of gastritis 1.5–7 years before the final diagnosis of adenocarcinoma. The adjacent gastritis mucosa within 10 mm from the carcinoma demonstrated MSI as well. MSI was not found in any of 35 patients with Helicobacter pylori infection, but found in one of 30 patients without infection. Moreover, two of three cases of gastric adenoma or well-differentiated adenocarcinoma with MSI-H at the stage of chronic gastritis showed no evidence of Helicobacter pylori infection throughout the observation periods. These results indicate that MSI in biopsy specimens at the stage of chronic gastritis may predict the risk of the progression to adenoma and well-differentiated adenocarcinoma, and that Helicobacter pylori infection itself may not induce MSI directly in the gastric mucosa. © 2000 Cancer Research Campaig
    corecore